Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov
CERTs banner

Journal Articles


One way of disseminating information learned from projects of the Centers for Education & Research on Therapeutics (CERTs) is through publication in peer-reviewed medical journals. This section shows CERTs journal articles published from 2000 through 2009.

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 

2002

A-E

  • Allen LaPointe NM, Kramer JM, DeLong E, et al. Patient-reported frequency of taking aspirin in a population with coronary artery disease. Am J Cardiol 2002 May 1;89(9):1042-1046. Select to access the abstract.
  • Allen LaPointe NM, Kramer JM, Weinfurt K, et al. Practitioner acceptance of the dofetilide risk-management program. Pharmacotherapy 2002 Aug;22(8):1041-1046. Select to access the abstract.
  • Andrade SE, Gurwitz JH, Chan KA, et al. Validation of diagnoses of peptic ulcers and bleeding from administrative databases. A multi-health maintenance organization study. J Clin Epidemiol 2002 Mar;55(3):310-313. Select to access the abstract.
  • Bisson GP, Fishman NO, Patel JB, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002 May;23(5):254-260. Select to access the abstract.
  • Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker after acute myocardial infarction. J Am Coll Cardiol 2002 Nov 6;40(9):1589-1595. Select to access the abstract.
  • Califf RM, Peterson ED, Gibbons RJ, et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 2002 Dec 4;40(11):1895-1901. Select to access the abstract.
  • Califf RM. The need for a national infrastructure to improve the rational use of therapeutics. Pharmacoepidemiol Drug Saf 2002 Jun;11(4):319-327. Select to access the abstract.
  • Califf RM, DeLong ER, Ostbye T, et al. Underuse of aspirin in a referral population with documented coronary artery disease. Am J Cardiol 2002 Mar 15;89(6):653-661. Select to access the abstract.
  • Casebeer L, Bennett N, Kristofco R, et al. Physician Internet medical information seeking and on-line continuing education use patterns. J Contin Educ Health Prof 2002 Winter;22(1):33-42. Select to access the abstract.
  • Casebeer L, James N. Practice pattern variation in the prevention and treatment of osteoporosis. Curr Opin Rheumatol 2002 Jul;14(4):453-457. Select to access the abstract.
  • Cooper WO, Griffin MR, Arbogast P, et al. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 2002 Jul;156(7):647-650. Select to access the abstract.
  • Cooper WO, Ray WA, Griffin MR. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 2002 Jul;100(1):101-106. Select to access the abstract.
  • Cooper WO, Staffa J, Renfrew JW, et al. Oral corticosteroid use among children in TennCare. Ambul Pediatr 2002 Sep-Oct;2(5):375-381. Select to access the abstract.
  • Donahue JG, Chan KA, Andrade SE, et al. Gastric and duodenal safety of daily alendronate. Arch Intern Med 2002 Apr 22;162(8):936-942. Select to access the abstract.

F-I

  • Flockhart DA, Usdin Yasuda S, et al. Teaching rational prescribing: a new clinical pharmacology curriculum for medical schools. Naunyn Schmiedebergs Arch Pharmacol 2002 Jul;366(1):33-43. Select to access the abstract.
  • Gross R, Bilker WB, Friedman HM, et al. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 2002 Sep 6;16(13):1835-1837. Select to access the abstract.
  • Hartert TV, Speroff T, Togias A, et al. Risk factors for recurrent asthma hospital visits and death among a population of indigent older adults with asthma. Ann Allergy Asthma Immunol 2002 Nov;89(5):467-473. Select to access the abstract.

J-N

  • Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go related gene (K)+ currents. J Pharmacol Exp Ther 2002 Nov;303(2):688-694. Select to access the abstract.
  • Kramer JM, Bosco LA, Califf RM. Centers for Education and Research on Therapeutics (CERTs). Drug Information Journal 2002;36:717-723.
  • Lautenbach E, Fishman NO, Bilker WB, et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 2002 Nov;162(21):2469-2477. Select to access the abstract.
  • Localio AR, Berlin JA, Ten Have TR. Confounding due to cluster in multicenter studies-causes and cures. Health Services & Outcomes Research Methodology 2002;3:195-210.
  • Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002 Sep;50(9):1484-1491. Select to access the abstract.
  • Metlay JP, Singer DE. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clin Microbiol Infect 2002;8 Supp 2:1-11. Select to access the abstract.
  • Metlay JP, Shea JA, Crossette LB, et al. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002 Feb;17:87-94. Select to access the abstract.
  • Metlay JP, Shea JA, Asch DA. Antibiotic prescribing decisions of generalists and infectious disease specialists: thresholds for adopting new drug therapies. Med Decis Making 2002 Nov-Dec;22(6):498-505. Select to access the abstract.
  • Mikuls TR, Saag KG, Criswell LA, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis 2002 Nov;61(11):994-999. Select to access the abstract.
  • Moellering Jr RC, Craig W, Edmond M, et al. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae. J Chemother 2002 Jul;14 Suppl 3:42-56. Select to access the abstract.
  • Netherlands Cancer Institute. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002 May;11(3):193-205.

O-Z

  • Putnam KG, Buist DS, Fishman P, et al. Chronic disease score as a predictor of hospitalization. Epidemiology 2002 May;13(3):340-346. Select to access the abstract.
  • Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002 Dec;11(8):663-669. Select to access the abstract.
  • Ray WA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev 2002 Dec;8(4):276-279. Select to access the abstract.
  • Ray WA, Stein CM, Daugherty JR, et al. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002 Oct 5;360(9339):1071-1073. Select to access the abstract.
  • Ray WA, Stein CM, Hall K, et al. Non-steroidal anti-inflammatory drugs and the risk of serious coronary heart disease: an observational cohort study. Lancet 2002 Jan 12;359(9301):118-123. Select to access the abstract.
  • Roper WL, Hodlewsky RT, Tilson H, et al. The potential impact of measuring healthcare quality on pharmaceutical-related costs and outcomes. Disease Management & Health Outcomes 2002;10:233-239.
  • Rosebraugh CJ, Honig PK, Yasuda SU, et al. Centers for Education and Research on Therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United States. Clin Pharmacol Ther 2002 Jan;71(1):4-10. Select to access the abstract.
  • Shatin D, Drinkard CR. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambul Pediatr 2002 Mar-Apr;2(2):111-119. Select to access the abstract.
  • Smalley W, Stein CM, Arbogast PG, et al. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 2002 Aug;46(8):2195-2200. Select to access the abstract.
  • Yasuda SU, Zannikos P, Young AE, et al. The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Br J Clin Pharmacol 2002 May;53(5):519-525. Select to access the abstract.

 

AHRQAdvancing Excellence in Health Care